The saphenous vein (SV) has been used as an aortocoronary bypass graft for coronary artery bypass grafting (CABG) for the past 50 years. However, CABG using the aortocoronary SV has shown disadvantages of lower long-term graft patency rates and subsequently worse clinical outcomes, compared with CABG using the internal thoracic artery (ITA). The advantages of CABG using the ITA prompted interest in total arterial revascularization, using the bilateral ITAs and other arterial conduits as composite graft configurations in patients exhibiting multi-vessel disease. Total arterial revascularization using a Y-or T-composite graft based on the in situ ITA increases the length of the arterial graft and allows the extensive use of arterial conduits to revascularize both the left and right coronary territories. Further, it has demonstrated favorable outcomes in terms of angiographic patency rates, myocardial perfusion and thickening by single photon emission computed tomography, and long-term clinical outcomes. However, previous studies describing the use of the SV conduit as a composite graft have produced conflicting results. In this article, a recent surgical strategy of using the SV as part of a composite graft based on the in situ left ITA will be discussed.
Introduction
The saphenous vein (SV) has been widely used for coronary artery bypass grafting (CABG) since the first planned use of the SV as an aortocoronary bypass graft by Favaloro in 1967 (1) . However, neointimal thickening, development of atherosclerosis of the SV conduit, lower patency and worse clinical outcomes have been reported after CABG using the aortocoronary SV compared with CABG using the internal thoracic artery (ITA) (2) (3) (4) . Methods to improve patency of the SV conduit include intraoperative pharmacologic treatment using vasodilating agents, postoperative optimal medical therapy such as antiplatelet and lipid-lowering agents, external support devices, intraoperative gene therapy and atraumatic harvesting techniques such as 'minimalmanipulation' or the 'no-touch' technique (5) (6) (7) (8) (9) (10) . Based on the safety and efficacy of total arterial revascularization using a Y-or T-composite graft connected to the in situ ITA (11) (12) (13) (14) , the SV has also been used as a composite graft with conflicting results. Herein, a recent surgical strategy of using the SV as part of a composite graft based on the in situ left ITA will be discussed.
Complete revascularization using a composite graft: pros and con Advantages such as reduced risk of reintervention and enhanced survival with the use of bilateral ITAs compared with a single ITA have increased interest in total arterial revascularization (15, 16) . Of total arterial revascularization strategies, construction of composite grafts based on the in situ ITA has advantages such as avoiding aortic manipulation and allowing efficient use of bypass conduits by increasing the graft length. Complete revascularization using a skeletonized arterial composite graft could be performed in majority of patients with multi-vessel coronary artery disease when combined with a sequential anastomotic technique (10, 17) .
There has been a concern that a composite graft based on the in situ ITA may not supply sufficient blood flow to a wider area of myocardium because it only emanates from a single blood source (18) . However, other studies have shown that CABG using composite grafts based on the left ITA were comparable with CABG using multiple inflows in terms of angiographic patency, improvement of myocardial perfusion and clinical outcomes (11) (12) (13) (14) (19) (20) (21) .
Complete revascularization using a SV composite graft
Although complete revascularization using an arterial composite graft has been demonstrated to be a safe and efficient method for revascularization (11) (12) (13) (14) , previous studies describing the use of the SV as a composite graft have produced conflicting results. One study, which included 25 patients who received an SV composite graft based on the ITA, demonstrated suboptimal shortterm patency (22) . Only 72% of the left ITA grafts were perfectly patent at average 2.5 years after surgery, probably because a large and less reactive SV connected to the ITA created flow diversion from the main stem of the Y graft and rendered the ITA distal to the Y graft more vulnerable to competitive flow. In contrast, other studies demonstrated comparable hemodynamic characteristics, early and midterm patency results between the SV and arterial composite grafts (10, (23) (24) (25) .
One hemodynamic study measured the pressure gradient and fractional flow reserve of composite conduits made with the right ITA or SV based on the in situ left ITA in 17 patients (10 right ITAs vs. 7 SVs patients) (23) . Hemodynamics of the right ITA and SV composite grafts were similar in terms of pressure gradients at baseline and hyperemia, and fractional flow reserve. Another recent study measured graft flow using the intraoperative transit time flowmetry at baseline and dobutamine-induced stress, and demonstrated that both the left ITA and SV showed physiological adaptability according to the demand (24 (Figure 1) (25) .
Theoretical advantages of SV composite grafts based on the in situ ITA over an aortocoronary bypass graft include: (I) the SV conduit anastomosed to the ITA is exposed to less circulatory stress than a conduit anastomosed to the ascending aorta; (II) the SV composite graft is continuously exposed to endothelium-protective substances such as nitric oxide released from the ITA (10). Complete revascularization using a SV composite graft based on the in situ ITA also has advantages such as avoiding aortic manipulation and allowing efficient use of bypass conduits. The length of the SV needed to reach the target vessel is shorter than that of an aortocoronary SV graft when using a SV composite graft with a sequential anastomosis technique. The SV from a lower or upper leg is sufficient for complete revascularization in most patients with multivessel coronary artery disease. In the randomized trial comparing results of CABG using the right ITA vs. SV composite grafts (10), complete revascularization was performed using the SV from a lower leg in 108 of 112 SV group patients (96.4%), whereas additional conduits to lengthen the right ITA were required in 40 of 112 right ITA group patients (35.7%).
Conclusions
Recent studies showed equivalent results between SV and arterial composite grafts in terms of early and mid-term graft patency rates and clinical outcomes. However, there are still concerns regarding the long-term patency of the SV composite graft, because of pathological changes in SV grafts, such as neointimal hyperplasia and atherosclerosis, which evolve very slowly over several years postoperatively. Long-term angiographic and clinical follow-up may be needed to demonstrate that the advantages of SV composite grafting are sufficient to overcome the previously published advantages of the right ITA over the SV as an additional A B C
